Victory

Save lives! End the lawsuit so preparations for a Phase III Clinical Trial of the GP2 Breast Cancer Vaccine can begin with an IND.

This petition made change with 2,088 supporters!


 

Please help! Many of us have been excited about the research results on breast cancer vaccines presented by MD Anderson. One such vaccine for Her2+ patients called GP2 has some truly amazing results.

Unfortunately, The Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) has filed a lawsuit against the vaccine developer, Norwell Inc. This lawsuit had been appealed to the federal level.  While women are waiting and praying against a recurrence, HJF is adding further potentional delays with their recent appeal to the Fourth Circuit Court (case #14-1580).

This vaccine has the potential to help decrease recurrence in Ovarian Cancer as well.  But, we have to get research moving forward to save lives.

Please help us urge them to end the lawsuit!

More data can be seen here:

Novel Immunotherapy GP2 Vaccine Decreases Recurrence in HER2 Positive Breast Cancer Patients


If you have a personal story or experience you would like to share, please write to the following people and urge them to use their influence to end the lawsuit and begin preparations for a Phase III Clinical Trial!

Mark Scher, Ph.D.
Director, Technology Transfer & Communication
The Henry M. Jackson Foundation for the Advancement of Military Medicine
6720A Rockledge Dr., Suite 100
Bethesda, MD 20817
mscher@hjf.org

If you would like to review the lawsuit and ruling under appeal by HJF, it can be viewed here:
https://www.dropbox.com/s/9uz2fqhm4knwy8d/HJF%20v%20Norwell.pdf?dl=0

Every attempt has been made to make sure information is accurate by reaching out to both HJF and Norwell.  

An email response was received from HJF to a member of our HER2+ Breast Cancer Support Group, however the email states that "This message is intended only for the use of the individual(s) to whom it is addressed and may contain information that is confidential, privileged, or otherwise exempt from disclosure under applicable law.  If you are not an intended recipient of this message, please notify the sender immediately and delete/destroy all copies of this message and any attachments." Therefore, the information in this email can not be disclosed.

An attempt has been made to reach out to Norwell for their response, however no direct response has been received at this time.






Today: T is counting on you

T Monks needs your help with “Director Mark Scher, Ph.D: Save lives! End the lawsuit so preparations for a Phase III Clinical Trial of the GP2 Breast Cancer Vaccine can begin with an IND.”. Join T and 2,087 supporters today.